Review of pseudobulbar affect including a novel and potential therapy.
about
PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditionsAnti-Yo Mediated Paraneoplastic Cerebellar Degeneration Associated with Pseudobulbar Affect in a Patient with Breast Cancer.Behaviour, physiology and experience of pathological laughing and crying in amyotrophic lateral sclerosis.Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA(®)) for Pseudobulbar Affect.Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affectPseudobulbar affect: the spectrum of clinical presentations, etiologies and treatments.Medical management of frontotemporal dementias: the importance of the caregiver in symptom assessment and guidance of treatment strategiesPoststroke depression and emotional incontinence: factors related to acute and subacute stages.PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.Psychiatric manifestations of neurologic disease: where are we headed?A study of potential pharmacokinetic and pharmacodynamic interactions between dextromethorphan/quinidine and memantine in healthy volunteers.Nuedexta for the treatment of pseudobulbar affect: a condition of involuntary crying or laughing.Mood and Anxiety Symptoms in Psychiatric Inpatients with Autism Spectrum Disorder and Depression.Dextromethorphan/quinidine sulfate for pseudobulbar affect.Prevalence of pseudobulbar affect symptoms and clinical correlates in nursing home residentsManagement of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options.An open-label study to assess safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in dementia: PRISM II results.Recognizing and treating pseudobulbar affect.Therapeutic Approach of a High Functioning Individual With Traumatic Brain Injury and Subsequent Emotional Volatility With Features of Pathological Laughter and Crying With Dextromethorphan/Quinidine.Altered resting-state functional activity in isolated pontine infarction patients with pathological laughing and crying.Dextromethorphan-quinidine-responsive pseudobulbar affect (PBA): psychopharmacological model for wide-ranging disorders of emotional expression?Factors associated with post-stroke depression and emotional incontinence: lesion location and coping styles.
P2860
Q21132546-636950EA-FE67-4CD4-87CB-272BB81A4DA9Q30252719-8CB6A001-0AD2-442B-8A90-F79365F87AA4Q30460222-4024FCEF-5F0A-438E-9C08-29025EDC99B9Q30634431-45F26CDA-4A7C-47BD-8B3A-9DC44576CD8AQ33838839-6373881A-BC4A-4841-9F78-9F872313E253Q34026748-5A3ADA3F-4030-4CE1-B04F-83DFBBF7E512Q35523924-D2904F6A-B8EE-46D0-9EB8-E7B4E94555A6Q35872340-41F9E135-8827-40BA-BF27-9FE70DE96CC1Q36045307-0F1B076F-B223-4FD1-9456-14D7E791A6C8Q36922117-3746661D-77BA-41C6-8E65-204594709044Q37021521-02B5AC2F-2560-4F52-B3D8-F9D3BF2D2071Q37081555-3711128D-91C9-48F3-ACB1-E061FC036B1AQ37140877-86CABD07-14E6-469A-A407-B67C51DBDD7BQ37366440-EB534A85-7DCD-4124-9CC7-42147B766520Q37561654-2AADA4AC-FDCC-4F4A-9F8F-EAFB9BE7BB74Q38391397-A772FF96-4826-47DD-A5B5-9BBF5A9F2ECEQ38401900-B14DD42D-BA29-4111-A09F-5F57073A694DQ39065476-B5345B2C-7969-4BF4-BDC0-2DEA2A1283C8Q41164001-F84EF8FA-2097-478B-9149-981FB7AB5C63Q46163587-8619E96C-D9E2-4A4C-ABA7-F1BA55B5141AQ47371943-4570E38F-EC91-4A50-9831-3C3846623768Q48082274-E21C8F1B-F8A4-496F-AD32-FB9EEE92D5AF
P2860
Review of pseudobulbar affect including a novel and potential therapy.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Review of pseudobulbar affect including a novel and potential therapy.
@ast
Review of pseudobulbar affect including a novel and potential therapy.
@en
Review of pseudobulbar affect including a novel and potential therapy.
@nl
type
label
Review of pseudobulbar affect including a novel and potential therapy.
@ast
Review of pseudobulbar affect including a novel and potential therapy.
@en
Review of pseudobulbar affect including a novel and potential therapy.
@nl
prefLabel
Review of pseudobulbar affect including a novel and potential therapy.
@ast
Review of pseudobulbar affect including a novel and potential therapy.
@en
Review of pseudobulbar affect including a novel and potential therapy.
@nl
P356
P1476
Review of pseudobulbar affect including a novel and potential therapy.
@en
P2093
Laura E Pope
Randolph Schiffer
P304
P356
10.1176/JNP.17.4.447
P577
2005-01-01T00:00:00Z